1. Home
  2. WKHS vs SABS Comparison

WKHS vs SABS Comparison

Compare WKHS & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WKHS
  • SABS
  • Stock Information
  • Founded
  • WKHS 2007
  • SABS 2014
  • Country
  • WKHS United States
  • SABS United States
  • Employees
  • WKHS N/A
  • SABS N/A
  • Industry
  • WKHS Auto Manufacturing
  • SABS Biotechnology: Pharmaceutical Preparations
  • Sector
  • WKHS Consumer Discretionary
  • SABS Health Care
  • Exchange
  • WKHS Nasdaq
  • SABS Nasdaq
  • Market Cap
  • WKHS 33.5M
  • SABS 32.1M
  • IPO Year
  • WKHS N/A
  • SABS N/A
  • Fundamental
  • Price
  • WKHS $0.71
  • SABS $3.53
  • Analyst Decision
  • WKHS Sell
  • SABS Strong Buy
  • Analyst Count
  • WKHS 3
  • SABS 5
  • Target Price
  • WKHS $5.75
  • SABS $12.40
  • AVG Volume (30 Days)
  • WKHS 3.4M
  • SABS 69.6K
  • Earning Date
  • WKHS 03-11-2025
  • SABS 11-06-2024
  • Dividend Yield
  • WKHS N/A
  • SABS N/A
  • EPS Growth
  • WKHS N/A
  • SABS N/A
  • EPS
  • WKHS N/A
  • SABS N/A
  • Revenue
  • WKHS $9,097,780.00
  • SABS $1,512,723.00
  • Revenue This Year
  • WKHS N/A
  • SABS N/A
  • Revenue Next Year
  • WKHS $80.00
  • SABS N/A
  • P/E Ratio
  • WKHS N/A
  • SABS N/A
  • Revenue Growth
  • WKHS N/A
  • SABS N/A
  • 52 Week Low
  • WKHS $0.57
  • SABS $2.16
  • 52 Week High
  • WKHS $8.18
  • SABS $6.30
  • Technical
  • Relative Strength Index (RSI)
  • WKHS 38.92
  • SABS 46.39
  • Support Level
  • WKHS $0.67
  • SABS $3.50
  • Resistance Level
  • WKHS $0.92
  • SABS $4.35
  • Average True Range (ATR)
  • WKHS 0.07
  • SABS 0.41
  • MACD
  • WKHS -0.00
  • SABS -0.07
  • Stochastic Oscillator
  • WKHS 13.55
  • SABS 19.22

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: